AzTrials
AzTrials

MalocclusionNCT07119814

Comparison of Outcome of Safe T Separators and Conventional Elastomeric Separators

A study testing Conventional Separators placement and Safe T separator in people with Malocclusion, run by Khyber College of dentistry at 1 site in Pakistan.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

All participants in this study will be provided with information concerning the study's objectives, and benefits associated with participation. Participants will be informed that their involvement in this study presents no potential risks associated with their participation. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Malocclusion
What is being tested?
Conventional Separators placement and Safe T separator
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 sitePakistan
Study dates
1 Dec 2025to 15 Apr 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age range (18-40) Years Male/Female Patients undergoing fixed orthodontic treatment as mentioned in operational

Who cannot join

  • Patients with poor oral hygiene Patients with periodontal conditions Patients failed to provide consent form

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Pakistan1 site
  • Khyber college of dentistry peshawar

    Peshawar, KPK, 25000

    Haris Mustafa, Bachelor in dental surgery, 0919221391, muslim.khan@kcd.edu.pk

Other trials in Pakistan

About this study

All participants in this study will be provided with information concerning the study's objectives, and benefits associated with participation. Participants will be informed that their involvement in this study presents no potential risks associated with their participation. Written consent will be obtained with appropriate information provided. Demographic data like age, BMI, gender, residence, socio economic status, occupation status, and literacy status will be documented. Patients undergoing fixed orthodontic treatment will be allocated in two groups equally by using the blocked randomization technique. Patients in Group A will undergo safe-T separators i.e initial thickness of Safe-T separators will be 1mm, Patients in Group B will undergo conventional elastomeric separators i.e thickness of elastomeric separators will be 1.2 mm. Separators will be positioned on either side of lower arch, each type of separator will be in sites, resulting in a sites within the lower arch. A separator placement tool will be utilised to position the separators. The comprehensive assessment will be carried out under the supervision of a consultant possessing at least five years of post-fellowship experience. Patient data will be recorded using a predefined structured proforma.

Conditions
Malocclusion
Being tested
Conventional Separators placement, Safe T separator
Medical subject headings
Malocclusion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional Separators placementDevice

    Safe T separators and conventional elastomeric separators will be placed in patients of fixed orthodontic treatment.

  • Safe T separatorDevice

    Safe T separators will be placed in patients of fixed orthodontic treatment

Study groups in NCT07119814
Study groupRoleWhat they receive
group A was assigned to Conventional elastomeric separators and group B to safe T separator groupOtherPlacement of conventional elastomeric separators and safe T separators intraorally in patients coming for fixed orthodontic treatment.
Receives: Device: Conventional Separators placement; Device: Safe T separator

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Amount of Pain

    Measuring the amount of pain caused by the two modalities of treatment using visual analogue scale

    Measured: Pain will be measured over 3 days of stsrting treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2025
  2. Study start1 Dec 2025 (estimated)
  3. Primary completion31 Mar 2026 (estimated)
  4. Study completion15 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
66 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07119814
Sponsor's protocol ID
59/RRB/KCD
Status last verified
Aug 2025
First submitted
6 Aug 2025
Last updated
13 Aug 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Conventional Separators placement and Safe T separator in people with Malocclusion, run by Khyber College of dentistry at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Amount of Pain (time frame: Pain will be measured over 3 days of stsrting treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in